BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 7724180)

  • 21. Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy.
    Quiram PA; Gonzales CR; Hu W; Gupta A; Yoshizumi MO; Kreiger AE; Schwartz SD
    Ophthalmology; 2006 Nov; 113(11):2041-7. PubMed ID: 16952397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and complications associated with perfluoro-n-octane and perfluoroperhydrophenanthrene in complex retinal detachment repair.
    Scott IU; Murray TG; Flynn HW; Smiddy WE; Feuer WJ; Schiffman JC
    Ophthalmology; 2000 May; 107(5):860-5. PubMed ID: 10811075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relaxing peripheral retinotomy with endolaser in treatment of retinal detachment with severe anterior proliferative vitreoretinopathy].
    Li X; Jiang Y
    Zhonghua Yan Ke Za Zhi; 1998 Nov; 34(6):411-4. PubMed ID: 11877240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraocular mitomycin C use in the treatment and prophylaxis of proliferative vitreoretinopathy in severe traumatic retinal detachments.
    Gürelik G; Sül S; Üçgül AY
    Eur J Ophthalmol; 2021 Nov; 31(6):3284-3293. PubMed ID: 33233948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment for chronic hypotony and anterior proliferative vitreoretinopathy.
    Lewis H; Verdaguer JI
    Am J Ophthalmol; 1996 Aug; 122(2):228-35. PubMed ID: 8694091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postoperative perfluoro-N-octane tamponade for primary retinal detachment repair.
    Rush R; Sheth S; Surka S; Ho I; Gregory-Roberts J
    Retina; 2012 Jun; 32(6):1114-20. PubMed ID: 21968506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vitrectomy in proliferative vitreoretinopathy. Anatomical and functional results in 501 patients].
    Körner F; Böhnke M
    Klin Monbl Augenheilkd; 1995 Apr; 206(4):239-45. PubMed ID: 7791283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relaxing retinotomies. Analysis of anatomic and visual results.
    Morse LS; McCuen BW; Machemer R
    Ophthalmology; 1990 May; 97(5):642-7; discussion 647-8. PubMed ID: 2342810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent retinal detachment more than 1 year after reattachment.
    Foster RE; Meyers SM
    Ophthalmology; 2002 Oct; 109(10):1821-7. PubMed ID: 12359601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application of perfluorocarbon liquids in vitrectomy].
    Jiang Y; Li X; Ye C
    Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):33-5. PubMed ID: 11835771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relaxing retinopathies and liquid perfluorocarbons].
    Morel C; Doan S; Rivoal O; Ameline B; Monin C; Larricart P
    J Fr Ophtalmol; 1998 May; 21(5):315-20. PubMed ID: 9759424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined pars plana vitrectomy-scleral buckle versus pars plana vitrectomy for proliferative vitreoretinopathy.
    Lai FH; Lo EC; Chan VC; Brelen M; Lo WL; Young AL
    Int Ophthalmol; 2016 Apr; 36(2):217-24. PubMed ID: 26260357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary vitrectomy for pseudophakic retinal detachment: a prospective non-randomized study.
    Pournaras CJ; Kapetanios AD
    Eur J Ophthalmol; 2003 Apr; 13(3):298-306. PubMed ID: 12747652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical application of perfluorotributylamine liquid in the complicated retinal detachment].
    Zhu X; Jiang D
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):253-5. PubMed ID: 12016798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitrectomy for rhegmatogenous or tractional retinal detachment with familial exudative vitreoretinopathy.
    Ikeda T; Fujikado T; Tano Y; Tsujikawa K; Koizumi K; Sawa H; Yasuhara T; Maeda K; Kinoshita S
    Ophthalmology; 1999 Jun; 106(6):1081-5. PubMed ID: 10366074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical management of traumatic retinal detachment with perfluorocarbon liquid. The Vitreon Study Group.
    Soheilian M; Peyman GA; Wafapoor H; Navarro GC; Thompson H
    Int Ophthalmol; 1996-1997; 20(5):241-9. PubMed ID: 9112194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy.
    Lewis H; Aaberg TM; Abrams GW
    Am J Ophthalmol; 1991 Jan; 111(1):8-14. PubMed ID: 1985496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of perfluorocarbon liquids in vitreous surgery.
    Claes C; Zivojnovic R
    Bull Soc Belge Ophtalmol; 1990; 238():145-50. PubMed ID: 2131117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relaxing retinotomies and retinectomies in the management of retinal detachment with severe proliferative vitreoretinopathy (PVR).
    Shalaby KA
    Clin Ophthalmol; 2010 Oct; 4():1107-14. PubMed ID: 20957056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of giant retinal tears without scleral buckling. Use of radical dissection of the vitreous base and perfluoro-octane and intraocular tamponade.
    Kreiger AE; Lewis H
    Ophthalmology; 1992 Apr; 99(4):491-7. PubMed ID: 1584565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.